Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Characteristics and Microbiology of Community-Acquired Pneumonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03098914
Recruitment Status : Unknown
Verified April 2017 by Liu chao, Beijing Haidian Hospital.
Recruitment status was:  Recruiting
First Posted : April 4, 2017
Last Update Posted : April 5, 2017
Sponsor:
Collaborators:
Beijing Tsinghua Chang Gung Hospital
Chinese PLA General Hospital
Information provided by (Responsible Party):
Liu chao, Beijing Haidian Hospital

Brief Summary:
Community-Acquired Pneumonia has become common. Additionally, the mortality is high. But the epidemiology of pathogen is various in different areas, which is crucial for the key treatment. In addition, the risk factors of patients who died in 3 or 7 days in china is not clear, comparing with patients who died in 14 or 28 days or who survived.

Condition or disease Intervention/treatment
Community-acquired Pneumonia Other: Cohort Study; pathogen; clinical features

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Clinical Characteristics and Microbiology of Community-Acquired Pneumonia: A Prospective Study
Estimated Study Start Date : April 11, 2017
Estimated Primary Completion Date : April 1, 2019
Estimated Study Completion Date : May 1, 2019

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Beijing Haidian Hospital Other: Cohort Study; pathogen; clinical features
Cohort Study; pathogen; clinical features

Chinese PLA General Hospital Other: Cohort Study; pathogen; clinical features
Cohort Study; pathogen; clinical features

Beijing Tsinghua Chang gung Hospital Other: Cohort Study; pathogen; clinical features
Cohort Study; pathogen; clinical features




Primary Outcome Measures :
  1. the epidemiology of pathogen of community-acquired pneumonia in the three hospitals [ Time Frame: confirmed as community-acquired pneumonia (2 weeks) ]
    screen out the pathogen of community-acquired pneumonia


Secondary Outcome Measures :
  1. risk factors of patients who died in 3 or 7 days [ Time Frame: in one week(3 days or 7days) ]
    patients who die in 3 or 7 days



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with commnuity acquired pneumonia
Criteria

Inclusion Criteria:

  • Confirmed community acquired pneumonia
  • Age≥18 ys

Exclusion Criteria:

  • HIV infection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03098914


Locations
Layout table for location information
China, Beijing
Beijing Haidian Hospital Recruiting
Beijing, Beijing, China, 100000
Contact: Liu Chao, Master    +86 18614043137    liuchao3619@163.com   
Sponsors and Collaborators
Beijing Haidian Hospital
Beijing Tsinghua Chang Gung Hospital
Chinese PLA General Hospital
Layout table for additonal information
Responsible Party: Liu chao, Doctor, Beijing Haidian Hospital
ClinicalTrials.gov Identifier: NCT03098914    
Other Study ID Numbers: Beijing Haidian Hospital
First Posted: April 4, 2017    Key Record Dates
Last Update Posted: April 5, 2017
Last Verified: April 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Liu chao, Beijing Haidian Hospital:
Pathogen
Mortality
Community-acquired Pneumonia
Risk factors
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections